EcoDrugPlus

Estrogen Related Receptor Gamma

Ensembl ID : ENSEEUG00000010749
Gene Symbol: ESRRG
1 External references
206 Possible Orthologues:

Exportin 1

Ensembl ID : ENSEEUG00000009479
Gene Symbol: XPO1
1 External references
296 Possible Orthologues:

Farnesyl Diphosphate Synthase

Ensembl ID : ENSEEUG00000001671
Gene Symbol: FDPS
1 External references
268 Possible Orthologues:

Farnesyl-Diphosphate Farnesyltransferase 1

Ensembl ID : ENSEEUG00000013655
Gene Symbol: FDFT1
1 External references
218 Possible Orthologues:

Farnesyltransferase, Caax Box, Alpha

Ensembl ID : ENSEEUG00000008272
Gene Symbol: FNTA
4 External references
222 Possible Orthologues:

Farnesyltransferase, Caax Box, Beta

Ensembl ID : ENSEEUG00000003778
Gene Symbol: FNTB
1 External references
211 Possible Orthologues:

Fatty Acid Amide Hydrolase

Ensembl ID : ENSEEUG00000014285
Gene Symbol: FAAH
1 External references
131 Possible Orthologues:

Fibroblast Activation Protein Alpha

Ensembl ID : ENSEEUG00000012268
Gene Symbol: FAP
1 External references
127 Possible Orthologues:

Fibroblast Growth Factor Receptor 1

Ensembl ID : ENSEEUG00000015789
Gene Symbol: FGFR1
1 External references
293 Possible Orthologues:

Fibroblast Growth Factor Receptor 2

Ensembl ID : ENSEEUG00000004024
Gene Symbol: FGFR2
1 External references
218 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 1

Ensembl ID : ENSEEUG00000014914
Gene Symbol: FLT1
1 External references
199 Possible Orthologues:

Fms Related Receptor Tyrosine Kinase 3

Ensembl ID : ENSEEUG00000009552
Gene Symbol: FLT3
1 External references
134 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).